Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?

Reported by Yahoo Finance · Published 24 Aug 2026, 3:54 AM MYT (2 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Liquor industry struggles grow with another Chapter 7 filing 27 min ago Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run 40 min ago The Metals Company Is Riding the Critical Metals Boom. Here's Why I Still Wouldn't Touch It. 58 min ago One Social Security Move Boomers Used to Boost Their Checks Is Now Off-Limits to Almost Everyone Else. 58 min ago Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying? 1 hr ago SK Hynix Is Buying Back 3.3% of Its Shares and Canceling Every One 1 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?

Summary

More in Markets

Liquor industry struggles grow with another Chapter 7 filing

Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run

The Metals Company Is Riding the Critical Metals Boom. Here's Why I Still Wouldn't Touch It.

One Social Security Move Boomers Used to Boost Their Checks Is Now Off-Limits to Almost Everyone Else.

Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?

SK Hynix Is Buying Back 3.3% of Its Shares and Canceling Every One